These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38355641)

  • 21. Predicting the impact of placing an overdose prevention site in Philadelphia: a mathematical modeling approach.
    Wares JR; Dong J; Gevertz JL; Radunskaya A; Viner K; Wiebe D; Solomon S
    Harm Reduct J; 2021 Oct; 18(1):110. PubMed ID: 34717657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "It wasn't here, and now it is. It's everywhere": fentanyl's rising presence in Oregon's drug supply.
    Shin SS; LaForge K; Stack E; Pope J; Leichtling G; Larsen JE; Leahy JM; Seaman A; Hoover D; Chisholm L; Blazes C; Baker R; Byers M; Branson K; Korthuis PT
    Harm Reduct J; 2022 Jul; 19(1):76. PubMed ID: 35818072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using alone at home: What's missing in housing-based responses to the overdose crisis?
    Fleming T; Boyd J; Chayama KL; Knight KR; McNeil R
    Harm Reduct J; 2024 Jan; 21(1):24. PubMed ID: 38281992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rapid-cycle assessment strategy for understanding the opioid overdose epidemic in local communities.
    Taubenberger S; Spencer N; Chang JC; Paul N; Fabre S; Jagessar B; Trimble D; Roberto R; Gill P; Hulsey E; Arnold A; Hacker K
    Subst Abus; 2021; 42(4):888-895. PubMed ID: 33689674
    [No Abstract]   [Full Text] [Related]  

  • 25. Community perspectives on supervised consumption sites: Insights from four U.S. counties deeply affected by opioids.
    Taylor J; Ober AJ; Kilmer B; Caulkins JP; Iguchi MY
    J Subst Abuse Treat; 2021 Dec; 131():108397. PubMed ID: 34098293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The implementation of overdose prevention sites as a novel and nimble response during an illegal drug overdose public health emergency.
    Wallace B; Pagan F; Pauly BB
    Int J Drug Policy; 2019 Apr; 66():64-72. PubMed ID: 30708237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "That's why we're speaking up today": exploring barriers to overdose fatality prevention in Indianapolis' Black community with semi-structured interviews.
    Seo DC; Satterfield N; Alba-Lopez L; Lee SH; Crabtree C; Cochran N
    Harm Reduct J; 2023 Oct; 20(1):159. PubMed ID: 37891632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Everybody is impacted. Everybody's hurting": Grief, loss and the emotional impacts of overdose on harm reduction workers.
    Kolla G; Khorasheh T; Dodd Z; Greig S; Altenberg J; Perreault Y; Bayoumi AM; Kenny KS
    Int J Drug Policy; 2024 May; 127():104419. PubMed ID: 38599035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users.
    Wallace B; van Roode T; Pagan F; Phillips P; Wagner H; Calder S; Aasen J; Pauly B; Hore D
    Harm Reduct J; 2020 May; 17(1):29. PubMed ID: 32398090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Awareness and knowledge of the Good Samaritan Drug Overdose Act among people at risk of witnessing an overdose in British Columbia, Canada: a multi-methods cross sectional study.
    Ackermann E; Kievit B; Xavier J; Barbic S; Ferguson M; Greer A; Loyal J; Mamdani Z; Palis H; Pauly B; Slaunwhite A; Buxton JA
    Subst Abuse Treat Prev Policy; 2022 May; 17(1):42. PubMed ID: 35614474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overdose Prevention Site Acceptability among Residents and Businesses Surrounding a Proposed Site in Philadelphia, USA.
    Roth AM; Kral AH; Mitchell A; Mukherjee R; Davidson P; Lankenau SE
    J Urban Health; 2019 Jun; 96(3):341-352. PubMed ID: 31168733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug use behaviors, trauma, and emotional affect following the overdose of a social network member: A qualitative investigation.
    Macmadu A; Frueh L; Collins AB; Newman R; Barnett NP; Rich JD; Clark MA; Marshall BDL
    Int J Drug Policy; 2022 Sep; 107():103792. PubMed ID: 35816791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "Another tool in the toolkit"-Perceptions, suggestions, and concerns of emergency service providers about the implementation of a supervised consumption site.
    Perlmutter D; Wettemann C; Fockele CE; Frohe T; Williams W; Holland N; Oliphant-Wells T; Meischke H; van Draanen J
    Int J Drug Policy; 2023 May; 115():104005. PubMed ID: 36972652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "We have to be uncomfortable and creative": Reflections on the impacts of the COVID-19 pandemic on overdose prevention, harm reduction & homelessness advocacy in Philadelphia.
    Aronowitz SV; Engel-Rebitzer E; Lowenstein M; Meisel Z; Anderson E; South E
    SSM Qual Res Health; 2021 Dec; 1():100013. PubMed ID: 34870265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The estimated costs and benefits of a hypothetical supervised consumption site in Providence, Rhode Island.
    Chambers LC; Hallowell BD; Zang X; Rind DM; Guzauskas GF; Hansen RN; Fuchs N; Scagos RP; Marshall BDL
    Int J Drug Policy; 2022 Oct; 108():103820. PubMed ID: 35973341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 'It's our safe sanctuary': Experiences of using an unsanctioned overdose prevention site in Toronto, Ontario.
    Foreman-Mackey A; Bayoumi AM; Miskovic M; Kolla G; Strike C
    Int J Drug Policy; 2019 Nov; 73():135-140. PubMed ID: 31654936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Having a voice and saving lives: a qualitative survey on employment impacts of people with lived experience of drug use working in harm reduction.
    ; Austin T; Boyd J
    Harm Reduct J; 2021 Jan; 18(1):1. PubMed ID: 33407500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gendered violence and overdose prevention sites: a rapid ethnographic study during an overdose epidemic in Vancouver, Canada.
    Boyd J; Collins AB; Mayer S; Maher L; Kerr T; McNeil R
    Addiction; 2018 Dec; 113(12):2261-2270. PubMed ID: 30211453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Facilitators and barriers to post-overdose service delivery in Rhode Island emergency departments: A qualitative evaluation.
    Collins AB; Beaudoin FL; Samuels EA; Wightman R; Baird J
    J Subst Abuse Treat; 2021 Nov; 130():108411. PubMed ID: 34118703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Challenges and Opportunities to Engaging Emergency Medical Service Providers in Substance Use Research: A Qualitative Study.
    Maragh-Bass AC; Fields JC; McWilliams J; Knowlton AR
    Prehosp Disaster Med; 2017 Apr; 32(2):148-155. PubMed ID: 28122657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.